Molbio Diagnostics Limited (BOM:544866)

Molbio Diagnostics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Cash & Equivalents	-	3,555	1,147	221.1	69.75
Short-Term Investments	-	150.87	143.06	1.09	2.64
Cash & Short-Term Investments	3,706	3,706	1,291	222.19	72.39
Cash Growth	-	187.18%	480.83%	206.94%	-
Accounts Receivable	-	4,097	2,717	4,254	1,888
Other Receivables	-	163.22	49.39	75.01	110.22
Receivables	-	4,261	2,766	4,329	1,998
Inventory	-	4,493	4,359	3,151	3,470
Prepaid Expenses	-	23.5	17.62	8.07	6.12
Other Current Assets	-	1,366	865.04	520.44	620.99
Total Current Assets	-	13,848	9,298	8,232	6,167
Property, Plant & Equipment	-	3,148	2,602	1,837	1,965
Long-Term Investments	-	351.31	507.8	59.86	60.05
Goodwill	-	621.28	38.41	38.41	38.41
Other Intangible Assets	-	1,708	527.8	704.16	912.38
Long-Term Accounts Receivable	-	1.13	-	-	-
Long-Term Deferred Tax Assets	-	515.53	469.43	291.12	104.42
Other Long-Term Assets	-	1,291	1,078	1,048	1,072
Total Assets	-	21,484	14,616	12,211	10,342

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Accounts Payable	-	1,995	2,302	939.88	855.22
Accrued Expenses	-	479.51	344.13	505.15	325.53
Short-Term Debt	-	1,802	1,058	1,490	1,057
Current Portion of Long-Term Debt	-	200.04	112.65	104.54	17.16
Current Portion of Leases	-	102.35	63.55	44.14	32.46
Current Unearned Revenue	-	159.82	60.68	73.22	94.45
Other Current Liabilities	-	834.57	475.98	270.7	193.28
Total Current Liabilities	-	5,574	4,417	3,428	2,575
Long-Term Debt	-	2,124	61.44	151.23	9.85
Long-Term Leases	-	272.03	174.14	46.34	68.51
Pension & Post-Retirement Benefits	-	95.66	40.53	18.96	15.28
Long-Term Deferred Tax Liabilities	-	331.14	2.94	31.03	52.59
Other Long-Term Liabilities	-	-	247	247	247
Total Liabilities	-	8,396	4,943	3,922	2,969

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Common Stock	-	112.76	22.56	22.54	22.54
Additional Paid-In Capital	-	1,959	1,959	1,949	1,949
Retained Earnings	-	9,227	7,647	6,203	5,184
Comprehensive Income & Other	-	395.35	56.17	59.67	59.67
Total Common Equity	11,693	11,693	9,684	8,234	7,215
Minority Interest	-	1,394	-11.06	54.56	158.62
Shareholders' Equity	13,088	13,088	9,673	8,288	7,373
Total Liabilities & Equity	-	21,484	14,616	12,211	10,342

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Total Debt	4,501	4,501	1,469	1,836	1,185
Net Cash (Debt)	-794.59	-794.59	-178.78	-1,614	-1,113
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-7.05	-7.05	-1.59	-14.31	-9.89
Filing Date Shares Outstanding	112.76	115.24	112.8	112.68	112.51
Total Common Shares Outstanding	112.76	112.76	112.8	112.68	112.51
Working Capital	-	8,275	4,882	4,804	3,592
Book Value Per Share	103.70	103.70	85.85	73.07	64.13
Tangible Book Value	9,364	9,364	9,118	7,491	6,264
Tangible Book Value Per Share	83.04	83.04	80.83	66.48	55.68
Land	-	329.69	329.69	-	-
Buildings	-	755.42	595.22	595.22	593.77
Machinery	-	2,829	2,271	2,010	1,894
Construction In Progress	-	113.21	273.31	15.83	-
Leasehold Improvements	-	57.87	2.7	2.6	2.6

Data Source: S&P Global Market Intelligence Last updated: Sep 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error